Navigation Links
Marketing of Low Tar Cigarette Brand by BAT Unethical

An online study published in the Lancet has revealed how British American Tobacco (BAT), a leading cigarette manufacturer has been adopting a strategy to mask the toxicity of the manufactured cigarettes. //

In an audit conducted to review the internal documents of the company by Canadian researchers, it has been found that the cigarettes actually delivered elevated levels of tar and nicotine under real life situations, while in documentation, it was claimed to produce a low yield.

Furthermore, that BAT was aware that real life smokers actually draw twice as much of the puff volume of the International Standards Smoking (ISO) machine, commonly used in testing protocols. In spite of the above observation, the company had been found to hide the difference in marketing campaigns and labels printed on cigarette packs.

Alarmingly, these cigarettes with high tar and nicotine yield were projected as low tar alternatives to smokers concerned about their health. The company even ignored most of the ethical concerns that were raised by senior scientists, a part of the parent organization.

'Overall, these documents depict a deliberate strategy whereby BAT and ITL (Imperial Tobacco Limited) designed products that would fool their consumers and regulators into thinking these products were safer or less hazardous when they were not. Moreover, this product strategy remains in place today, as does the tool of its deception, the ISO cigarette testing protocols. The current review leaves little doubt that the ISO standards should be discarded in favor of new standards that meet the needs of consumers and regulators, rather than those of the tobacco industry, ' concluded the authors of the present study.


'"/>




Page: 1

Related medicine news :

1. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
2. Junk Food Marketing to be banned
3. Government Should Restrict Junk Food Marketing
4. Kellogg Warned Against Its Marketing Strategies
5. Bayer Wins Positive Response For Marketing Its Cancer Drug
6. Co-op to Stop Marketing Diabetic Food
7. Measures to Streamline Marketing of Breast-Milk Substitutes
8. Marketing in Schools may Discourage Healthy Nutrition among Students
9. Viagra Marketing Campaign, ‘a Cause of Concern’, Say Anti-AIDS Grop
10. Effective Marketing of Multivitamins Essential
11. FDA Announces to Companies to Stop Marketing Products Containing Trimethobenzamide
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
(Date:4/26/2017)... Doylestown, Pa. (PRWEB) , ... ... ... Solutions division, which provides an agile ecosystem and domain expertise for sponsors ... end-to-end, configurable randomization and trial supply management (RTSM) software platform. Bioclinica ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... 2017 , ... Lake Park Dental is now accepting new patients with crooked ... FL. With the help of this highly-effective, yet convenient system, patients can straighten their ... and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: